1 Result: CTMX
Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody(TM) Therapeutics for the Treatment of Cancer and Other Diseases
March 20th, 2017
* Builds upon initial 2014 alliance in oncology * Includes up to eight additional targets in oncology and other therapeutic areas * CytomX to receive $200 million upfront payment NEW YORK and SOUTH SAN FRANCISCO / CRWE PRESS RELEASE / March 20, . Read more
Want To Find Some News?
News By Industries
March 24th, 2017March 23rd, 2017March 22nd, 2017March 22nd, 2017March 21st, 2017